Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Home Lung Transplantation Mortality rates are similar after single and double lung transplants in autoimmune diseases with ILD

Mortality rates are similar after single and double lung transplants in autoimmune diseases with ILD

by News Source
0 comments

December 12, 2024

2 minute read


Your request could not be processed. Please try again later. If you continue to experience this issue, please contact us at customerservice@slackinc.com.

WASHINGTON — Systemic autoimmune rheumatoid arthritis patients who develop interstitial lung disease have a similar 1-year risk of death after a single or double lung transplant, data show.

The findings, presented at ACR Convergence 2024, show that single-lung transplantation can effectively increase the number of lungs available for transplantation for patients with end-stage lung disease due to ILD and systemic autoimmune rheumatic diseases (SARDs). This suggests that it is a reasonable strategy. said the lead author.



lung
“This study is the first of its kind to evaluate the impact of single and double lung transplant patients on SARD-ILD.” Dr. Harry Hurley, Said. Image: Adobe Stock

“Similar 1-year mortality rates have been demonstrated for other forms of ILD, including idiopathic pulmonary fibrosis (IPF).” Dr. Harry Hurley, Albert Einstein College of Medicine professor told attendees: “However, there was another study showing that overall survival was longer for IPF patients who received a double lung transplant (DLT) than a single lung transplant (SLT). So, naturally, our question… Is there any benefit to DLT for patients with SARD ILD?”

To compare the outcomes of single and double lung transplants in patients with SARD-ILD, Hurley et al. conducted a retrospective cohort study using data from the Organ Sharing Network. This study consisted of procedures performed from May 4, 2005 to December 31, 2019.

The analysis included 606 adults (mean age 54 years, 59% women) with SARD-ILD, 37% of whom had systemic sclerosis. We compared 1-year mortality between the two procedures using a stratified Cox model adjusted for donor, recipient, and procedure characteristics. Some missing covariate data were filled by multiple imputation.

Overall, 76% of the cohort underwent double lung transplantation. According to the researchers, the unadjusted 1-year mortality rate was 17.24 deaths per 100 person-years for single-lung transplants and 14.97 deaths for double-lung transplants.

Additionally, single lung transplantation was significantly less likely than double lung transplantation in either the unadjusted model (HR = 1.19; 95% CI, 0.75-1.19) or the fully adjusted model (HR = 1.49; 95% CI, 0.75-1.19). It was not associated with a significant increase in 1-year mortality. 95% CI, 0.34-6.57).

The risk of death in the two groups over a one-year period was “comparable,” Hurley said.

“This study is the first of its kind to evaluate the impact of single and double lung transplant patients on SARD-ILD,” he added. “We were able to control for a number of possible confounders and therefore believe that this accurately reflects modern transplant outcomes in SARD-ILD. There is a need to prospectively study adult SARD-ILD patients during the transplant evaluation process to identify risk factors and improve outcomes.”

news source

You may also like

About Us

Welcome to Daily Transplant News, your trusted source for the latest updates, stories, and information on transplantation and organ donations. We are passionate about sharing the inspiring journeys, groundbreaking research, and invaluable resources surrounding the world of transplantation.

About Us

Welcome to Daily Transplant News, your trusted source for the latest updates, stories, and information on transplantation and organ donations. We are passionate about sharing the inspiring journeys, groundbreaking research, and invaluable resources surrounding the world of transplantation.

Copyright ©️ 2024 Daily Transplant News | All rights reserved.